• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Author's reply to correspondence on "Expanding the Use of HIPEC in Ovarian Cancer at Interval Debulking Surgery to FIGO Stage IV and After 6 Cycles of Neoadjuvant Chemotherapy: A Prospective Analysis and Perioperative and Oncologic Outcomes" by Mukurdipi Ray et al.

作者信息

Ghirardi V, Trozzi R, Scambia G, Fagotti A

机构信息

Division of Gynecologic Oncology, Fondazione Policlinico Universitario A. Gemelli - IRCCS, Rome, Italy.

Universita' Cattolica del Sacro Cuore, Rome, Italy.

出版信息

Ann Surg Oncol. 2024 Aug;31(8):5121. doi: 10.1245/s10434-024-15503-6. Epub 2024 May 30.

DOI:10.1245/s10434-024-15503-6
PMID:38814550
Abstract
摘要

相似文献

1
Author's reply to correspondence on "Expanding the Use of HIPEC in Ovarian Cancer at Interval Debulking Surgery to FIGO Stage IV and After 6 Cycles of Neoadjuvant Chemotherapy: A Prospective Analysis and Perioperative and Oncologic Outcomes" by Mukurdipi Ray et al.作者对Mukurdipi Ray等人关于“在中间性肿瘤细胞减灭术中将腹腔热灌注化疗扩展应用于FIGO IV期卵巢癌及新辅助化疗6周期后的应用：一项前瞻性分析及围手术期和肿瘤学结局”的通信的回复
Ann Surg Oncol. 2024 Aug;31(8):5121. doi: 10.1245/s10434-024-15503-6. Epub 2024 May 30.
2
Correspondence on "Expanding the Use of HIPEC in Ovarian Cancer at Interval Debulking Surgery to FIGO Stage IV and After 6 Cycles of Neoadjuvant Chemotherapy: A Prospective Analysis and Perioperative and Oncologic Outcomes" by Valentina Ghirardi et al.关于瓦伦蒂娜·吉拉尔迪等人所著的《在中间性肿瘤细胞减灭术中将腹腔热灌注化疗（HIPEC）的应用扩展至国际妇产科联盟（FIGO）IV期卵巢癌以及新辅助化疗6周期后：一项前瞻性分析及围手术期和肿瘤学结局》的通信
Ann Surg Oncol. 2024 Jul;31(7):4582-4583. doi: 10.1245/s10434-024-15399-2. Epub 2024 May 4.
3
Expanding the Use of HIPEC in Ovarian Cancer at Time of Interval Debulking Surgery to FIGO Stage IV and After 6 Cycles of Neoadjuvant Chemotherapy: A Prospective Analysis on Perioperative and Oncologic Outcomes.在间隔减瘤手术时将 HIPEC 扩大用于 FIGO 分期为 IV 期和新辅助化疗 6 周期后的卵巢癌：一项关于围手术期和肿瘤学结果的前瞻性分析。
Ann Surg Oncol. 2024 May;31(5):3350-3360. doi: 10.1245/s10434-024-15042-0. Epub 2024 Feb 27.
4
A novel treatment protocol with 6 cycles of neoadjuvant chemotherapy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in stage III primary ovarian cancer.在 III 期原发性卵巢癌中，采用新辅助化疗 6 个周期，随后进行细胞减灭术和腹腔热灌注化疗（HIPEC）的新治疗方案。
Surg Oncol. 2021 Jun;37:101523. doi: 10.1016/j.suronc.2021.101523. Epub 2021 Jan 31.
5
Critical Analysis of Stage IV Epithelial Ovarian Cancer Patients after Treatment with Neoadjuvant Chemotherapy followed by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC).新辅助化疗后细胞减灭术和腹腔热灌注化疗（CRS/HIPEC）治疗的 IV 期上皮性卵巢癌患者的批判性分析。
Int J Surg Oncol. 2020 Dec 16;2020:1467403. doi: 10.1155/2020/1467403. eCollection 2020.
6
Pattern of recurrence after interval cytoreductive surgery and HIPEC following neoadjuvant chemotherapy in primary advanced stage IIIC/IVA epithelial ovarian cancer.新辅助化疗后间隔细胞减灭术和 HIPEC 治疗原发性晚期 IIIC/IVA 上皮性卵巢癌的复发模式。
Eur J Surg Oncol. 2021 Jun;47(6):1427-1433. doi: 10.1016/j.ejso.2021.01.013. Epub 2021 Jan 22.
7
Assessing feasibility and perioperative outcomes with minimally invasive surgery compared with laparotomy for interval debulking surgery with hyperthermic intraperitoneal chemotherapy for advanced epithelial ovarian cancer.评估微创与剖腹手术相比在晚期上皮性卵巢癌间歇性肿瘤细胞减灭术联合腹腔热灌注化疗中的可行性和围手术期结局。
Gynecol Oncol. 2021 Jan;160(1):45-50. doi: 10.1016/j.ygyno.2020.09.052. Epub 2020 Oct 14.
8
Upfront debulking surgery versus interval debulking surgery for advanced tubo-ovarian high-grade serous carcinoma and diffuse peritoneal metastases treated with peritonectomy procedures plus HIPEC.新辅助肿瘤细胞减灭术与间隔性肿瘤细胞减灭术治疗腹膜假黏液瘤的疗效比较：一项回顾性队列研究
J Surg Oncol. 2019 Dec;120(7):1208-1219. doi: 10.1002/jso.25703. Epub 2019 Sep 17.
9
Neoadjuvant systemic and hyperthermic intraperitoneal chemotherapy combined with cytoreductive surgery for gastric cancer patients with limited peritoneal metastasis: a prospective cohort study.新辅助全身化疗联合腹腔内热灌注化疗联合细胞减灭术治疗合并腹膜转移限制的胃癌患者：一项前瞻性队列研究。
BMC Cancer. 2020 Nov 16;20(1):1108. doi: 10.1186/s12885-020-07601-x.
10
Cytoreduction and HIPEC after neoadjuvant chemotherapy in stage IIIC-IV ovarian cancer. Critical analysis in elderly patients.新辅助化疗后IIIC-IV期卵巢癌的肿瘤细胞减灭术和腹腔热灌注化疗。老年患者的批判性分析。
Eur J Obstet Gynecol Reprod Biol. 2014 Aug;179:88-93. doi: 10.1016/j.ejogrb.2014.05.018. Epub 2014 Jun 2.

引用本文的文献

1
ASO Author Reflections: Expanding the Use of HIPEC in Ovarian Cancer at Time of Interval Debulking Surgery.ASO作者反思：在间歇性减瘤手术时扩大热灌注化疗在卵巢癌中的应用
Ann Surg Oncol. 2024 Jul;31(7):4580-4581. doi: 10.1245/s10434-024-15124-z. Epub 2024 Mar 6.

本文引用的文献

1
Expanding the Use of HIPEC in Ovarian Cancer at Time of Interval Debulking Surgery to FIGO Stage IV and After 6 Cycles of Neoadjuvant Chemotherapy: A Prospective Analysis on Perioperative and Oncologic Outcomes.在间隔减瘤手术时将 HIPEC 扩大用于 FIGO 分期为 IV 期和新辅助化疗 6 周期后的卵巢癌：一项关于围手术期和肿瘤学结果的前瞻性分析。
Ann Surg Oncol. 2024 May;31(5):3350-3360. doi: 10.1245/s10434-024-15042-0. Epub 2024 Feb 27.
2
Survival Effect of Maximal Cytoreductive Surgery for Advanced Ovarian Carcinoma During the Platinum Era: A Meta-Analysis.最大程度减瘤术治疗铂类时代晚期卵巢癌的生存效果：一项荟萃分析。
J Clin Oncol. 2023 Sep 1;41(25):4065-4076. doi: 10.1200/JCO.22.02765.
3
Cytoreductive or debulking surgery in ovarian cancer: The name does matter!
卵巢癌的肿瘤细胞减灭术或肿瘤缩减术：名称很重要！
J Surg Oncol. 2021 May;123(8):1846-1847. doi: 10.1002/jso.26432. Epub 2021 Mar 22.
4
Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma.卵巢癌初始治疗中肿瘤主体的手术切除。
Natl Cancer Inst Monogr. 1975 Oct;42:101-4.